Other Events ·
LivaNova PLC held its 2026 Annual General Meeting of Shareholders on June 10, 2026
LIVNLivaNova PLC
LivaNova PLC held its 2026 Annual General Meeting of Shareholders on June 10, 2026. Shareholders approved ten proposals, including the election of eleven directors for terms expiring in 2027, the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm, and the adoption of the company's audited UK statutory accounts for the year ended December 31, 2025. Additionally, shareholders authorized the directors to allot shares up to an aggregate nominal amount of £10,985,296 and approved terms for share repurchase contracts limited to 10% of the total issued Ordinary Shares. LivaNova PLC is a medical technology company that develops and manufactures products for cardiovascular and respiratory markets.